MSF is supporting two survivors of DR-TB in challenging a patent in India on a new tuberculosis drug to increase affordable access. Should the patent challenge be successful, generic versions could be available four years earlier, saving thousands of lives. Go to Source Date: February 8, 2019 at 09:01 Author: – joanna.keenan

error: Content is protected !!